Skip to content
healthcare.dev

Gabapentin

NDC 16571-226, Gabapentin, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-226
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217995
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN600 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
16571-226-0116571022601100 TABLET in 1 BOTTLE (16571-226-01)
16571-226-5016571022650500 TABLET in 1 BOTTLE (16571-226-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8215da86-d7af-4980-b6d6-4bd46f6bfeaf
  • NADAC price for package 16571022601

    GET /v1/drugs/nadac/16571022601
  • NADAC price for package 16571022650

    GET /v1/drugs/nadac/16571022650

Use it

Look up 16571-226 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.